May 10, 2017 / 11:39 AM / 3 months ago

BRIEF-Adaptimmune Q1 loss per share $0.05

May 10 (Reuters) - Adaptimmune Therapeutics Plc

* Adaptimmune reports first quarter 2017 financial results

* Q1 revenue $2.9 million

* Q1 revenue view $4.9 million -- Thomson Reuters I/B/E/S

* Adaptimmune therapeutics plc - offerings in march and april raised net proceeds of $103.2 million; operations funded through to late 2019

* Q1 loss per share $0.05 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below